Phathom Pharmaceuticals (PHAT) Debt Ratio (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Debt Ratio data on file, last reported at 0.54 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 22.35% year-over-year to 0.54 in Q1 2026; TTM through Mar 2026 was 0.54, a 22.35% decrease from a year earlier, with the FY2025 full-year figure at 0.81, up 51.55% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.54, down from 0.81 in the prior quarter.
• Over the last five years, Debt Ratio for PHAT reached as high as 0.86 in Q3 2025 and fell as low as 0.33 in Q4 2023.
• Historically, Debt Ratio has averaged 0.56 across 5 years, with a median of 0.54 in 2026.
• Across the five-year window, Debt Ratio jumped 217.78% in 2022 and slumped 42.38% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.58 in 2022, then slumped by 42.38% to 0.33 in 2023, then soared by 59.84% to 0.53 in 2024, then soared by 51.55% to 0.81 in 2025, then sank by 33.51% to 0.54 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.54 in Q1 2026, 0.81 in Q4 2025, and 0.86 in Q3 2025.